Innovating Biotechnology for a Self-Reliant India

Active Pharmaceutical Ingredients (APIs)

  • Definition: Active Pharmaceutical Ingredients (APIs) are the biologically active components in medicines that produce the intended therapeutic effect, distinguishing them from inactive excipients like fillers or binders.
  • Function: APIs are the molecular backbone of drugs, synthesized or derived to target specific diseases—e.g., Penicillin G combats bacterial infections, while Lovastatin lowers cholesterol—through precise chemical or biological processes.
  • Global Market Scale: The API market surpassed USD 255 billion in 2024, with projections to reach USD 405 billion by 2034 (CAGR 6.9%), driven by rising healthcare demands (MarketsandMarkets; Pharmexcil).
  • Production Dominance: Chemical synthesis leads with a 71% market share in 2023, producing 80–90% of small-molecule APIs, while biological methods (e.g., microbial fermentation) account for 28.27% in 2024, fueling biologics growth (McKinsey; USP).
  • Economic Impact: APIs constitute 20–30% of drug costs globally, inflating prices by 25% in the U.S. alone; India’s API imports were valued at USD 4.5 billion in 2023–24, with 70–72% sourced from China (USP; Pharmexcil).
  • Health Significance: APIs underpin 60% of the world’s generic drugs and 20% of vaccines, serving 7.8 billion people; demand is surging—e.g., 2.5 million new cancer cases annually require API-driven therapies (WHO).
  • Innovation Potential: The microbial API segment was valued at USD 58.04 billion in 2022 and is poised to hit USD 108.59 billion by 2034 (CAGR 6.66%), signaling a shift toward greener, scalable production methods (Fortune Business Insights).
  • Global Relevance: With 665 FDA-approved API plants in India and 40–60.5% of global supply from China, APIs are a linchpin in healthcare—yet supply and sustainability vulnerabilities demand transformative solutions worldwide (Pharmexcil).
Problem That We Are Solving